Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Bile Duct Neoplasms (Phase 1)
Breast Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Colorectal Neoplasms (Phase 1)
Digestive System Neoplasms (Phase 1)
Endometrial Neoplasms (Phase 1)
Esophageal Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1)
Hamartoma (Phase 1)
Hypopharyngeal Neoplasms (Phase 1)
Laryngeal Neoplasms (Phase 1)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Mesothelioma (Phase 1)
Mouth Neoplasms (Phase 1)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 1)
Oropharyngeal Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Penile Neoplasms (Phase 1)
Rhabdomyosarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Small Cell Lung Carcinoma (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue